Sight Sciences/$SGHT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sight Sciences
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Ticker
$SGHT
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
216
ISIN
US82657M1053
Website
Sight Sciences Metrics
BasicAdvanced
$178M
-
-$0.98
2.40
-
Price and volume
Market cap
$178M
Beta
2.4
52-week high
$8.45
52-week low
$2.03
Average daily volume
174K
Financial strength
Current ratio
10.469
Quick ratio
9.75
Long term debt to equity
51.413
Total debt to equity
52.124
Interest coverage (TTM)
-10.52%
Management effectiveness
Return on assets (TTM)
-21.77%
Return on equity (TTM)
-52.87%
Valuation
Price to revenue (TTM)
2.228
Price to book
2.28
Price to tangible book (TTM)
2.28
Price to free cash flow (TTM)
-7.121
Growth
Revenue change (TTM)
-4.16%
Earnings per share change (TTM)
-12.78%
3-year revenue growth (CAGR)
12.27%
3-year earnings per share growth (CAGR)
-21.79%
What the Analysts think about Sight Sciences
Analyst ratings (Buy, Hold, Sell) for Sight Sciences stock.
Sight Sciences Financial Performance
Revenues and expenses
Sight Sciences Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sight Sciences stock?
Sight Sciences (SGHT) has a market cap of $178M as of May 29, 2025.
What is the P/E ratio for Sight Sciences stock?
The price to earnings (P/E) ratio for Sight Sciences (SGHT) stock is 0 as of May 29, 2025.
Does Sight Sciences stock pay dividends?
No, Sight Sciences (SGHT) stock does not pay dividends to its shareholders as of May 29, 2025.
When is the next Sight Sciences dividend payment date?
Sight Sciences (SGHT) stock does not pay dividends to its shareholders.
What is the beta indicator for Sight Sciences?
Sight Sciences (SGHT) has a beta rating of 2.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.